샘플 요청 목록

 카트 문의
시장보고서
상품코드
1793032

세계의 마이크로어레이 키트 시장

Microarray Kits
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 377 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 마이크로어레이 키트 시장은 2030년까지 20억 달러에 도달

2024년에 16억 달러로 추정되는 마이크로어레이 키트 세계 시장은 2024-2030년간 CAGR 3.9%로 성장하여 2030년에는 20억 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 DNA 마이크로어레이 키트는 CAGR 3.2%를 나타내고, 분석 기간 종료시에는 9억 6,350만 달러에 이를 것으로 예측됩니다. RNA 마이크로어레이 키트 분야의 성장률은 분석 기간중 CAGR 5.0%로 추정됩니다.

미국 시장은 4억 2,290만 달러로 추정, 중국은 CAGR 7.1%로 성장 예측

미국의 마이크로어레이 키트 시장은 2024년에 4억 2,290만 달러로 추정됩니다. 세계 2위 경제대국인 중국은 2030년까지 3억 9,370만 달러 규모에 이를 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 7.1%로 추정됩니다. 기타 주목해야 할 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간중 CAGR은 각각 1.6%와 3.0%를 보일 것으로 예측됩니다. 유럽에서는 독일이 CAGR 2.3%를 나타낼 전망입니다.

세계의 마이크로어레이 키트 시장 - 주요 동향과 촉진요인 정리

마이크로어레이 키트는 유전체 연구와 진단의 최전선에서 어떻게 발전하고 있는가?

마이크로어레이 키트는 유전자 발현의 고처리량 분석, 유전형 분석, 분자 프로파일링의 탁월한 효율성으로 유전체 연구 및 바이오메디컬 연구의 기반이 되는 도구가 되고 있습니다. 이 키트는 수천 개의 DNA 프로브가 내장된 고체 표면을 이용하여 한 번의 실험으로 수천 개의 유전자 발현 수준과 돌연변이를 동시에 분석할 수 있습니다. 이 능력은 복잡한 유전자 상호작용과 질병 경로를 해독하는 데 필요한 시간, 노력, 자원을 줄임으로써 생물학적 연구를 혁신적으로 변화시켰습니다. 진단학에서 마이크로어레이 키트는 고유한 유전자 마커와 발현 패턴을 식별하여 암, 심혈관 질환, 신경 질환, 감염성 질환 등의 질병을 조기에 발견하고 위험도를 평가할 수 있도록 돕습니다. 개인 맞춤형 의료가 점점 더 활발해지고 있는 가운데, 임상의들은 개인의 유전자 프로파일에 따른 치료 계획을 세우기 위해 마이크로어레이 기반 검사를 점점 더 많이 이용하고 있습니다. 프로브 설계, 하이브리드화 화학 및 신호 증폭의 혁신은 민감도와 특이성을 크게 향상시켜 임상 및 연구 응용 분야 모두에서 마이크로어레이의 신뢰성을 높였습니다. 또한, 바이오인포매틱스 툴과의 통합을 통해 종합적인 데이터 분석이 가능해져 결과 해석이 강화되고 보다 정확한 의사결정을 내릴 수 있게 되었습니다. 차세대 마이크로어레이 키트는 멀티오믹스 접근법을 지원하여 DNA, RNA, 후성유전학적 변형을 한 번의 분석으로 동시에 검사할 수 있게 되었습니다. 이러한 범용성으로 인해 마이크로어레이의 응용 범위는 기초 연구부터 복잡한 임상 진단 및 의약품 개발까지 확대되고 있습니다. 비용이 계속 낮아지고 프로토콜이 더욱 간소화됨에 따라 마이크로어레이 기술은 소규모 실험실과 클리닉에서도 쉽게 사용할 수 있게 되어 학술, 상업 및 의료 기관 전반에 걸쳐 도입이 가속화되고 있습니다.

정밀의료와 바이오마커 탐색이 마이크로어레이 키트 수요를 촉진하는 이유는 무엇일까?

정밀의료로의 전환은 연구 및 임상 환경 모두에서 마이크로어레이 키트에 대한 수요 증가를 촉진하는 가장 중요한 요인 중 하나입니다. 헬스케어 시스템이 개인의 유전자 프로파일에 기반한 개인 맞춤형 치료를 지향하는 가운데, 바이오마커의 식별, 검증, 모니터링의 필요성이 급증하고 있습니다. 마이크로어레이 키트는 질병 감수성, 진행, 치료 반응과 관련된 바이오마커 후보물질의 하이스루풋 스크리닝을 위한 강력한 플랫폼을 제공합니다. 예를 들어, 종양학에서 마이크로어레이를 통한 유전자 발현 프로파일링은 종양을 분자 아형별로 계층화하여 치료 방침을 결정하고 예후를 예측하는 데 도움이 됩니다. 마찬가지로 자가면역질환이나 정신질환에서도 마이크로어레이를 이용한 분석을 통해 유전자 발현 시그니처를 밝혀내어 질병 분류와 약물 타겟팅에 도움을 주고 있습니다. 약리유전체학에서는 마이크로어레이를 통해 약물 대사에 영향을 미치는 유전자 변이를 평가할 수 있어 보다 안전하고 효과적인 치료 요법을 지원할 수 있습니다. 이러한 기능은 임상시험에서 특히 가치가 있으며, 분자 데이터에 기반한 환자 계층화는 시험 설계와 결과 해석을 개선할 수 있습니다. 제약사들이 표적치료제 개발에 주력하는 가운데, 동반진단제 개발에 마이크로어레이 키트의 활용이 확대되고 있습니다. 또한, 액체 생검과 같은 비침습적 검사 방법의 등장으로 동적 질병 추적을 위한 순환 핵산 모니터링에서 마이크로어레이의 역할이 더욱 강화되고 있습니다. 마이크로어레이의 풍부한 데이터 출력은 복잡한 데이터 세트를 분석하여 숨겨진 패턴과 예측 모델을 밝혀내는 인공지능 및 머신러닝 용도도 지원합니다. 이러한 요인들이 복합적으로 작용하여 바이오마커 중심의 환자 맞춤형 의료를 진행하는데 필수적인 도구로서 마이크로어레이 키트의 역할이 강화되고 있습니다.

기술 혁신은 마이크로어레이 키트의 성능과 사용 편의성을 어떻게 향상시키고 있는가?

기술의 발전은 마이크로어레이 키트의 기능, 접근성, 효율성을 끊임없이 변화시키며 다양한 분야에서 그 유용성을 확장하고 있습니다. 주요 개선 사항 중 하나는 어레이의 소형화로, 더 많은 프로브를 더 작은 표면에 더 많은 프로브를 집어넣을 수 있어 시약 소비와 분석 시간을 줄이면서 데이터 출력을 증가시킬 수 있습니다. 또한, 새로운 인쇄 기술과 표면 화학적 방법을 통해 프로브 고정이 강화되어 더 나은 하이브리드화 동역학 및 낮은 배경 잡음을 가능하게 합니다. 이러한 개발로 민감도와 특이도가 모두 개선되어 결과의 신뢰성과 재현성이 향상되었습니다. 시료 준비, 하이브리드화, 세척, 스캔을 완전히 통합한 마이크로어레이 플랫폼을 사용할 수 있게 되어 수작업으로 인한 실수를 줄이고 처리량을 향상시킬 수 있게 되었습니다. 이는 대량의 환자 샘플을 다루는 임상 실험실에 특히 유용합니다. 강화된 멀티플렉스 기능을 통해 연구자들은 한 번의 실행으로 여러 매개변수를 분석할 수 있어 워크플로우를 간소화하고 비용 효율성을 높일 수 있습니다. 또한, 마이크로어레이 키트는 혈액, 타액, 조직, 환경 시료 등 다양한 유형의 시료에 대응할 수 있어 활용도가 더욱 높아졌습니다. 클라우드 기반 데이터 분석 도구와 사용자 친화적인 소프트웨어 인터페이스는 전문가가 아니더라도 결과 해석을 간소화하여 고도로 훈련된 분자생물학자 이외의 사용자 기반을 넓히고 있습니다. 최근의 기술 혁신에는 휴대용 마이크로어레이 플랫폼과 랩온칩 시스템도 포함되어 자원이 제한된 환경에서 포인트 오브 케어 검사를 가능하게 하는 기술 혁신이 포함됩니다. 이러한 모바일 솔루션은 신속하고 정확한 진단이 필수적인 감염성 질환 감시 등 다양한 분야에 적용이 검토되고 있습니다. 인공지능과 머신러닝이 마이크로어레이 기술과 통합되면서 패턴 인식과 예측 분석이 이러한 플랫폼의 능력을 더욱 향상시키고 있습니다. 전반적으로, 지속적인 기술 혁신은 마이크로어레이 키트를 더욱 견고하고 효율적으로 만들고, 현대 과학과 의료의 진화하는 요구에 더 잘 적응할 수 있도록 하고 있습니다.

마이크로어레이 키트 시장의 세계 성장을 가속하는 요인은 무엇인가?

마이크로어레이 키트 시장의 성장은 분자생물학의 발전, 개인 맞춤형 의료에 대한 수요 증가, 유전체 기술의 광범위한 도입과 관련된 여러 가지 상호 연관된 요인에 의해 주도되고 있습니다. 주요 성장 요인 중 하나는 전 세계적으로 만성질환과 유전성 질환의 부담이 증가하고 있으며, 이에 따라 정부와 의료 서비스 제공업체들은 조기 발견 및 예방 진단에 대한 투자를 강화하고 있습니다. 국가적 이니셔티브와 자금 지원 프로그램에 의해 지원되는 유전체 연구의 확대는 학술 및 제약 분야에서 마이크로어레이와 같은 하이스루풋 기술에 대한 수요를 증가시키고 있습니다. 제약사들은 신약 개발, 리드 화합물 최적화, 독성 테스트에 마이크로어레이 기반 분석을 도입하고 있으며, 이러한 키트는 초기 단계의 연구개발에 필수적인 요소로 자리 잡고 있습니다. 또 다른 중요한 요인은 전염병의 확산으로, 특히 병원체 식별이 시급한 발병 시나리오에서 신속한 다중 진단의 필요성이 증가하고 있다는 점입니다. 이와 함께 합성생물학 및 시스템 생물학의 발전은 대사공학, 유전자 기능 연구, 후성유전학 연구에서 마이크로어레이의 새로운 응용을 촉진하고 있습니다. 차세대 염기서열분석기(NGS)의 접근성 또한 마이크로어레이의 보완적 활용을 촉진하고 있으며, 특히 비용, 속도, 편의성 측면에서 마이크로어레이가 더 현실적인 선택이 될 수 있는 상황에서 활용되고 있습니다. 아시아태평양, 라틴아메리카, 중동의 신흥 시장은 헬스케어 인프라가 잘 갖추어지고 고급 진단에 대한 수요가 증가함에 따라 세계 성장에 기여하고 있습니다. 또한, 생명공학 기업, 진단 기업, 연구기관의 전략적 제휴를 통해 제품 혁신과 시장 침투가 가속화되고 있습니다. 유리한 규제 정책, 유전성 질환에 대한 인식 증가, 확장 가능한 진단 솔루션의 필요성이 시장 확대를 더욱 촉진하고 있습니다. 이러한 다양한 힘이 결합되어 세계 마이크로어레이 키트 시장은 강력하고 지속적인 성장 궤도를 그리고 있습니다.

부문

제품(DNA 마이크로어레이 키트, RNA 마이크로어레이 키트, Protein 마이크로어레이 키트, Tissue 마이크로어레이 키트);용도(Drug Discovery 및 연구개발 용도, 연구 용도, 진단 용도, 기타 용도);최종 용도(제약 기업 및 바이오테크놀러지 기업 최종 용도, CRO 최종 용도, 연구 및 학술기관 최종 용도,병원 및 진단실험실 최종 용도, 기타 최종 용도)

조사 대상 기업 예

  • Affymetrix Inc.
  • Agilent Technologies Inc.
  • Arrayit Corporation
  • Bio-Rad Laboratories Inc.
  • BioMerieux SA
  • CapitalBio Technology Co. Ltd
  • Danaher Corporation
  • Diasorin S.p.A.
  • Edvotek Inc.
  • F. Hoffmann-La Roche Ltd.
  • GE Healthcare Inc.
  • Illumina Inc.
  • Merck KGaA
  • Microarrays Inc.
  • Molecular Devices LLC
  • NextGen Sciences Inc.
  • PerkinElmer Inc.
  • Promega Corporation
  • RayBiotech Life Inc.
  • Thermo Fisher Scientific Inc.

AI 통합

Global Industry Analysts는 유효한 전문가 컨텐츠와 AI툴에 의해서, 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 일반적인 LLM나 업계별 SLM 쿼리에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수익원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

LSH 25.08.26

Global Microarray Kits Market to Reach US$2.0 Billion by 2030

The global market for Microarray Kits estimated at US$1.6 Billion in the year 2024, is expected to reach US$2.0 Billion by 2030, growing at a CAGR of 3.9% over the analysis period 2024-2030. DNA Microarray Kits, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$963.5 Million by the end of the analysis period. Growth in the RNA Microarray Kits segment is estimated at 5.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$422.9 Million While China is Forecast to Grow at 7.1% CAGR

The Microarray Kits market in the U.S. is estimated at US$422.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$393.7 Million by the year 2030 trailing a CAGR of 7.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.6% and 3.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.3% CAGR.

Global Microarray Kits Market - Key Trends & Drivers Summarized

How Are Microarray Kits Advancing the Frontiers of Genomic Research and Diagnostics?

Microarray kits have become a foundational tool in genomic and biomedical research, enabling high-throughput analysis of gene expression, genotyping, and molecular profiling with unparalleled efficiency. These kits utilize a solid surface embedded with thousands of DNA probes that can simultaneously analyze the expression levels or mutations of thousands of genes in a single experiment. This capacity has transformed biological research by reducing the time, labor, and resources required to decode complex genetic interactions and disease pathways. In diagnostics, microarray kits are facilitating early detection and risk assessment for conditions such as cancer, cardiovascular diseases, neurological disorders, and infectious diseases by identifying unique genetic markers or expression patterns. With personalized medicine gaining momentum, clinicians are increasingly using microarray-based tests to tailor treatment plans according to individual genetic profiles. Innovations in probe design, hybridization chemistry, and signal amplification have significantly improved sensitivity and specificity, making microarrays more reliable for both clinical and research applications. Additionally, integration with bioinformatics tools allows for comprehensive data analysis, enhancing the interpretation of results and enabling more precise decision-making. New generations of microarray kits now support multi-omics approaches, allowing simultaneous examination of DNA, RNA, and epigenetic modifications in a single assay. This versatility is broadening the scope of microarrays from basic research to complex clinical diagnostics and pharmaceutical development. As costs continue to decline and protocols become more streamlined, microarray technology is becoming more accessible to smaller labs and clinics, accelerating its adoption across academic, commercial, and medical institutions.

Why Are Precision Medicine and Biomarker Discovery Fueling Demand for Microarray Kits?

The global shift toward precision medicine is one of the most significant factors driving the increasing demand for microarray kits in both research and clinical environments. As healthcare systems strive to personalize therapies based on individual genetic profiles, the need to identify, validate, and monitor biomarkers has surged. Microarray kits provide a powerful platform for high-throughput screening of candidate biomarkers related to disease susceptibility, progression, and therapeutic response. In oncology, for instance, gene expression profiling via microarrays helps stratify tumors by molecular subtype, guiding treatment decisions and predicting prognosis. Similarly, in autoimmune diseases and psychiatric disorders, microarray-based analyses are uncovering gene expression signatures that inform disease classification and drug targeting. In pharmacogenomics, microarrays enable the assessment of genetic variations that affect drug metabolism, supporting safer and more effective treatment regimens. These capabilities are especially valuable in clinical trials, where patient stratification based on molecular data can improve study design and outcome interpretation. As pharmaceutical companies intensify efforts to develop targeted therapies, the use of microarray kits for companion diagnostic development is expanding. Additionally, the rise of non-invasive testing methods such as liquid biopsy is further enhancing the role of microarrays in monitoring circulating nucleic acids for dynamic disease tracking. The data-rich output of microarrays also supports artificial intelligence and machine learning applications, where complex datasets are analyzed to reveal hidden patterns and predictive models. Together, these factors are reinforcing the role of microarray kits as indispensable tools in the advancement of biomarker-driven and patient-specific medical care.

How Are Technological Innovations Enhancing Microarray Kit Performance and Usability?

Technological advancements are continuously reshaping the capabilities, accessibility, and efficiency of microarray kits, expanding their utility across various sectors. One of the key improvements is the miniaturization of arrays, which enables more probes to be packed onto smaller surfaces, increasing data output while reducing reagent consumption and assay time. New printing technologies and surface chemistries have also enhanced probe immobilization, allowing for better hybridization kinetics and lower background noise. These developments have improved both sensitivity and specificity, making results more reliable and reproducible. Automation has become a major trend, with fully integrated microarray platforms now available for sample preparation, hybridization, washing, and scanning, reducing manual errors and increasing throughput. This is particularly beneficial for clinical laboratories handling large volumes of patient samples. Enhanced multiplexing capabilities allow researchers to analyze multiple parameters in a single run, streamlining workflows and improving cost-effectiveness. Furthermore, the compatibility of microarray kits with different types of samples, including blood, saliva, tissue, and even environmental samples, adds to their versatility. Cloud-based data analysis tools and user-friendly software interfaces are simplifying result interpretation for non-specialists, expanding the user base beyond highly trained molecular biologists. Recent innovations also include portable microarray platforms and lab-on-a-chip systems that allow for point-of-care testing in resource-limited settings. These mobile solutions are being explored for applications such as infectious disease surveillance, where rapid and accurate diagnostics are essential. As artificial intelligence and machine learning become more integrated with microarray technologies, pattern recognition and predictive analytics are further enhancing the power of these platforms. Altogether, ongoing innovation is making microarray kits more robust, efficient, and adaptable to the evolving needs of modern science and healthcare.

What Factors Are Driving the Global Growth of the Microarray Kits Market?

The growth in the microarray kits market is driven by several interconnected factors related to advancements in molecular biology, increased demand for personalized medicine, and the widespread adoption of genomic technologies. One major growth driver is the rising global burden of chronic and genetic diseases, which is prompting governments and healthcare providers to invest more heavily in early detection and preventive diagnostics. The expansion of genomics research, supported by national initiatives and funding programs, is boosting demand for high-throughput technologies like microarrays in academic and pharmaceutical sectors. Pharmaceutical companies are increasingly incorporating microarray-based analyses in drug discovery, lead optimization, and toxicity testing, making these kits essential in early-phase research and development. Another significant factor is the growing prevalence of infectious diseases and the corresponding need for rapid, multiplex diagnostics, especially in outbreak scenarios where time-sensitive identification of pathogens is critical. In parallel, advances in synthetic biology and systems biology are fostering new applications for microarrays in metabolic engineering, gene function studies, and epigenetic research. The increasing accessibility of next-generation sequencing (NGS) has also driven complementary use of microarrays, particularly in scenarios where cost, speed, or simplicity make microarrays the more viable option. Emerging markets in Asia-Pacific, Latin America, and the Middle East are contributing to global growth as healthcare infrastructure improves and demand for advanced diagnostics rises. Additionally, strategic collaborations between biotech firms, diagnostics companies, and research institutions are accelerating product innovation and market penetration. Favorable regulatory policies, increased awareness of genetic disorders, and the need for scalable diagnostic solutions are further supporting market expansion. Together, these diverse forces are creating a strong and sustained growth trajectory for the global microarray kits market.

SCOPE OF STUDY:

The report analyzes the Microarray Kits market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits, Tissue Microarray Kits); Application (Drug Discovery & Development Application, Research Application, Diagnostics Application, Other Applications); End-Use (Pharma & Biotech Companies End-Use, CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

  • Affymetrix Inc.
  • Agilent Technologies Inc.
  • Arrayit Corporation
  • Bio-Rad Laboratories Inc.
  • BioMerieux SA
  • CapitalBio Technology Co. Ltd
  • Danaher Corporation
  • Diasorin S.p.A.
  • Edvotek Inc.
  • F. Hoffmann-La Roche Ltd.
  • GE Healthcare Inc.
  • Illumina Inc.
  • Merck KGaA
  • Microarrays Inc.
  • Molecular Devices LLC
  • NextGen Sciences Inc.
  • PerkinElmer Inc.
  • Promega Corporation
  • RayBiotech Life Inc.
  • Thermo Fisher Scientific Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Microarray Kits - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for High-Throughput Genomic Analysis Throws the Spotlight on Microarray Kits
    • Growth in Personalized Medicine and Targeted Therapies Drives Adoption of Gene Expression Profiling Kits
    • Expansion of Cancer Genomics Research Spurs Demand for Mutation Detection and Diagnostic Microarrays
    • Widening Application of Microarrays in Infectious Disease Surveillance Strengthens Market Opportunities
    • Cost-Effectiveness and Multiplexing Capabilities Propel Microarray Adoption in Academic and Clinical Labs
    • Advancements in Labeling and Detection Chemistries Generate Innovation in Kit Sensitivity and Accuracy
    • Pharmacogenomics Research and Drug Discovery Pipelines Accelerate Use of Custom Microarray Platforms
    • Increased Integration with Bioinformatics Tools Enhances the Value Proposition of Microarray-Based Analysis
    • Shift Toward Point-of-Care and Decentralized Testing Expands Addressable Market for Rapid Microarray Kits
    • Rising Prevalence of Genetic Disorders Fuels Demand for Prenatal and Rare Disease Microarray Testing
    • Competition from Next-Generation Sequencing (NGS) Technologies Creates Both Challenges and Innovation Pressure
    • Growing Adoption in Agricultural Genomics and Environmental Monitoring Spurs Diversification of Microarray Kit Applications
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Microarray Kits Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Microarray Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Microarray Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Microarray Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for DNA Microarray Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for DNA Microarray Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for DNA Microarray Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for RNA Microarray Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for RNA Microarray Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for RNA Microarray Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Protein Microarray Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Protein Microarray Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Protein Microarray Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Tissue Microarray Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Tissue Microarray Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Tissue Microarray Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for CROs End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for CROs End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for CROs End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Research & Academic Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Research & Academic Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Research & Academic Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Hospitals & Diagnostic Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Hospitals & Diagnostic Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Hospitals & Diagnostic Laboratories End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 28: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 31: World 16-Year Perspective for Pharma & Biotech Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Drug Discovery & Development Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Drug Discovery & Development Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 34: World 16-Year Perspective for Drug Discovery & Development Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Research Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Research Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 37: World 16-Year Perspective for Research Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 40: World 16-Year Perspective for Diagnostics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 43: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Microarray Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 44: USA Recent Past, Current & Future Analysis for Microarray Kits by Product - DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Microarray Kits by Product - DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 46: USA 16-Year Perspective for Microarray Kits by Product - Percentage Breakdown of Value Sales for DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits for the Years 2014, 2025 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Microarray Kits by End-Use - CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Microarray Kits by End-Use - CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 49: USA 16-Year Perspective for Microarray Kits by End-Use - Percentage Breakdown of Value Sales for CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use for the Years 2014, 2025 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for Microarray Kits by Application - Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Microarray Kits by Application - Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 52: USA 16-Year Perspective for Microarray Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Microarray Kits by Product - DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Microarray Kits by Product - DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 55: Canada 16-Year Perspective for Microarray Kits by Product - Percentage Breakdown of Value Sales for DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits for the Years 2014, 2025 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Microarray Kits by End-Use - CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Microarray Kits by End-Use - CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 58: Canada 16-Year Perspective for Microarray Kits by End-Use - Percentage Breakdown of Value Sales for CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use for the Years 2014, 2025 & 2030
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Microarray Kits by Application - Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Microarray Kits by Application - Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 61: Canada 16-Year Perspective for Microarray Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
  • JAPAN
    • Microarray Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Microarray Kits by Product - DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Microarray Kits by Product - DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 64: Japan 16-Year Perspective for Microarray Kits by Product - Percentage Breakdown of Value Sales for DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits for the Years 2014, 2025 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Microarray Kits by End-Use - CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Microarray Kits by End-Use - CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 67: Japan 16-Year Perspective for Microarray Kits by End-Use - Percentage Breakdown of Value Sales for CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use for the Years 2014, 2025 & 2030
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Microarray Kits by Application - Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Microarray Kits by Application - Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 70: Japan 16-Year Perspective for Microarray Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
  • CHINA
    • Microarray Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 71: China Recent Past, Current & Future Analysis for Microarray Kits by Product - DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Microarray Kits by Product - DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 73: China 16-Year Perspective for Microarray Kits by Product - Percentage Breakdown of Value Sales for DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits for the Years 2014, 2025 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Microarray Kits by End-Use - CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Microarray Kits by End-Use - CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 76: China 16-Year Perspective for Microarray Kits by End-Use - Percentage Breakdown of Value Sales for CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use for the Years 2014, 2025 & 2030
    • TABLE 77: China Recent Past, Current & Future Analysis for Microarray Kits by Application - Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Microarray Kits by Application - Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 79: China 16-Year Perspective for Microarray Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
  • EUROPE
    • Microarray Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Microarray Kits by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Microarray Kits by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for Microarray Kits by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Microarray Kits by Product - DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Microarray Kits by Product - DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 85: Europe 16-Year Perspective for Microarray Kits by Product - Percentage Breakdown of Value Sales for DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits for the Years 2014, 2025 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Microarray Kits by End-Use - CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Microarray Kits by End-Use - CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 88: Europe 16-Year Perspective for Microarray Kits by End-Use - Percentage Breakdown of Value Sales for CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use for the Years 2014, 2025 & 2030
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Microarray Kits by Application - Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Microarray Kits by Application - Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 91: Europe 16-Year Perspective for Microarray Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
  • FRANCE
    • Microarray Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 92: France Recent Past, Current & Future Analysis for Microarray Kits by Product - DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Microarray Kits by Product - DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 94: France 16-Year Perspective for Microarray Kits by Product - Percentage Breakdown of Value Sales for DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits for the Years 2014, 2025 & 2030
    • TABLE 95: France Recent Past, Current & Future Analysis for Microarray Kits by End-Use - CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Microarray Kits by End-Use - CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 97: France 16-Year Perspective for Microarray Kits by End-Use - Percentage Breakdown of Value Sales for CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use for the Years 2014, 2025 & 2030
    • TABLE 98: France Recent Past, Current & Future Analysis for Microarray Kits by Application - Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: France Historic Review for Microarray Kits by Application - Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 100: France 16-Year Perspective for Microarray Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
  • GERMANY
    • Microarray Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Microarray Kits by Product - DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Microarray Kits by Product - DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 103: Germany 16-Year Perspective for Microarray Kits by Product - Percentage Breakdown of Value Sales for DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits for the Years 2014, 2025 & 2030
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Microarray Kits by End-Use - CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for Microarray Kits by End-Use - CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 106: Germany 16-Year Perspective for Microarray Kits by End-Use - Percentage Breakdown of Value Sales for CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use for the Years 2014, 2025 & 2030
    • TABLE 107: Germany Recent Past, Current & Future Analysis for Microarray Kits by Application - Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Germany Historic Review for Microarray Kits by Application - Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 109: Germany 16-Year Perspective for Microarray Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Microarray Kits by Product - DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Microarray Kits by Product - DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 112: Italy 16-Year Perspective for Microarray Kits by Product - Percentage Breakdown of Value Sales for DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits for the Years 2014, 2025 & 2030
    • TABLE 113: Italy Recent Past, Current & Future Analysis for Microarray Kits by End-Use - CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for Microarray Kits by End-Use - CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 115: Italy 16-Year Perspective for Microarray Kits by End-Use - Percentage Breakdown of Value Sales for CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use for the Years 2014, 2025 & 2030
    • TABLE 116: Italy Recent Past, Current & Future Analysis for Microarray Kits by Application - Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Italy Historic Review for Microarray Kits by Application - Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 118: Italy 16-Year Perspective for Microarray Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Microarray Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 119: UK Recent Past, Current & Future Analysis for Microarray Kits by Product - DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Microarray Kits by Product - DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 121: UK 16-Year Perspective for Microarray Kits by Product - Percentage Breakdown of Value Sales for DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits for the Years 2014, 2025 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for Microarray Kits by End-Use - CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for Microarray Kits by End-Use - CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 124: UK 16-Year Perspective for Microarray Kits by End-Use - Percentage Breakdown of Value Sales for CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use for the Years 2014, 2025 & 2030
    • TABLE 125: UK Recent Past, Current & Future Analysis for Microarray Kits by Application - Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: UK Historic Review for Microarray Kits by Application - Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 127: UK 16-Year Perspective for Microarray Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 128: Spain Recent Past, Current & Future Analysis for Microarray Kits by Product - DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Spain Historic Review for Microarray Kits by Product - DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 130: Spain 16-Year Perspective for Microarray Kits by Product - Percentage Breakdown of Value Sales for DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits for the Years 2014, 2025 & 2030
    • TABLE 131: Spain Recent Past, Current & Future Analysis for Microarray Kits by End-Use - CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Spain Historic Review for Microarray Kits by End-Use - CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 133: Spain 16-Year Perspective for Microarray Kits by End-Use - Percentage Breakdown of Value Sales for CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use for the Years 2014, 2025 & 2030
    • TABLE 134: Spain Recent Past, Current & Future Analysis for Microarray Kits by Application - Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Spain Historic Review for Microarray Kits by Application - Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 136: Spain 16-Year Perspective for Microarray Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 137: Russia Recent Past, Current & Future Analysis for Microarray Kits by Product - DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Russia Historic Review for Microarray Kits by Product - DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 139: Russia 16-Year Perspective for Microarray Kits by Product - Percentage Breakdown of Value Sales for DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits for the Years 2014, 2025 & 2030
    • TABLE 140: Russia Recent Past, Current & Future Analysis for Microarray Kits by End-Use - CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Russia Historic Review for Microarray Kits by End-Use - CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 142: Russia 16-Year Perspective for Microarray Kits by End-Use - Percentage Breakdown of Value Sales for CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use for the Years 2014, 2025 & 2030
    • TABLE 143: Russia Recent Past, Current & Future Analysis for Microarray Kits by Application - Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Russia Historic Review for Microarray Kits by Application - Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 145: Russia 16-Year Perspective for Microarray Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Microarray Kits by Product - DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of Europe Historic Review for Microarray Kits by Product - DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 148: Rest of Europe 16-Year Perspective for Microarray Kits by Product - Percentage Breakdown of Value Sales for DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits for the Years 2014, 2025 & 2030
    • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Microarray Kits by End-Use - CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Rest of Europe Historic Review for Microarray Kits by End-Use - CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 151: Rest of Europe 16-Year Perspective for Microarray Kits by End-Use - Percentage Breakdown of Value Sales for CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use for the Years 2014, 2025 & 2030
    • TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Microarray Kits by Application - Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Rest of Europe Historic Review for Microarray Kits by Application - Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 154: Rest of Europe 16-Year Perspective for Microarray Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Microarray Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Microarray Kits by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Microarray Kits by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 16-Year Perspective for Microarray Kits by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Microarray Kits by Product - DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for Microarray Kits by Product - DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 160: Asia-Pacific 16-Year Perspective for Microarray Kits by Product - Percentage Breakdown of Value Sales for DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits for the Years 2014, 2025 & 2030
    • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Microarray Kits by End-Use - CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Asia-Pacific Historic Review for Microarray Kits by End-Use - CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 163: Asia-Pacific 16-Year Perspective for Microarray Kits by End-Use - Percentage Breakdown of Value Sales for CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use for the Years 2014, 2025 & 2030
    • TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for Microarray Kits by Application - Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Asia-Pacific Historic Review for Microarray Kits by Application - Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 166: Asia-Pacific 16-Year Perspective for Microarray Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Microarray Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 167: Australia Recent Past, Current & Future Analysis for Microarray Kits by Product - DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Australia Historic Review for Microarray Kits by Product - DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 169: Australia 16-Year Perspective for Microarray Kits by Product - Percentage Breakdown of Value Sales for DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits for the Years 2014, 2025 & 2030
    • TABLE 170: Australia Recent Past, Current & Future Analysis for Microarray Kits by End-Use - CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Australia Historic Review for Microarray Kits by End-Use - CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 172: Australia 16-Year Perspective for Microarray Kits by End-Use - Percentage Breakdown of Value Sales for CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use for the Years 2014, 2025 & 2030
    • TABLE 173: Australia Recent Past, Current & Future Analysis for Microarray Kits by Application - Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Australia Historic Review for Microarray Kits by Application - Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 175: Australia 16-Year Perspective for Microarray Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
  • INDIA
    • Microarray Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 176: India Recent Past, Current & Future Analysis for Microarray Kits by Product - DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: India Historic Review for Microarray Kits by Product - DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 178: India 16-Year Perspective for Microarray Kits by Product - Percentage Breakdown of Value Sales for DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits for the Years 2014, 2025 & 2030
    • TABLE 179: India Recent Past, Current & Future Analysis for Microarray Kits by End-Use - CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: India Historic Review for Microarray Kits by End-Use - CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 181: India 16-Year Perspective for Microarray Kits by End-Use - Percentage Breakdown of Value Sales for CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use for the Years 2014, 2025 & 2030
    • TABLE 182: India Recent Past, Current & Future Analysis for Microarray Kits by Application - Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: India Historic Review for Microarray Kits by Application - Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 184: India 16-Year Perspective for Microarray Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 185: South Korea Recent Past, Current & Future Analysis for Microarray Kits by Product - DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: South Korea Historic Review for Microarray Kits by Product - DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 187: South Korea 16-Year Perspective for Microarray Kits by Product - Percentage Breakdown of Value Sales for DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits for the Years 2014, 2025 & 2030
    • TABLE 188: South Korea Recent Past, Current & Future Analysis for Microarray Kits by End-Use - CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: South Korea Historic Review for Microarray Kits by End-Use - CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 190: South Korea 16-Year Perspective for Microarray Kits by End-Use - Percentage Breakdown of Value Sales for CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use for the Years 2014, 2025 & 2030
    • TABLE 191: South Korea Recent Past, Current & Future Analysis for Microarray Kits by Application - Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: South Korea Historic Review for Microarray Kits by Application - Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 193: South Korea 16-Year Perspective for Microarray Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Microarray Kits by Product - DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Asia-Pacific Historic Review for Microarray Kits by Product - DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 196: Rest of Asia-Pacific 16-Year Perspective for Microarray Kits by Product - Percentage Breakdown of Value Sales for DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits for the Years 2014, 2025 & 2030
    • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Microarray Kits by End-Use - CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Asia-Pacific Historic Review for Microarray Kits by End-Use - CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 199: Rest of Asia-Pacific 16-Year Perspective for Microarray Kits by End-Use - Percentage Breakdown of Value Sales for CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use for the Years 2014, 2025 & 2030
    • TABLE 200: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Microarray Kits by Application - Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Asia-Pacific Historic Review for Microarray Kits by Application - Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 202: Rest of Asia-Pacific 16-Year Perspective for Microarray Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Microarray Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Microarray Kits by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Microarray Kits by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 205: Latin America 16-Year Perspective for Microarray Kits by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 206: Latin America Recent Past, Current & Future Analysis for Microarray Kits by Product - DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Latin America Historic Review for Microarray Kits by Product - DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 208: Latin America 16-Year Perspective for Microarray Kits by Product - Percentage Breakdown of Value Sales for DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits for the Years 2014, 2025 & 2030
    • TABLE 209: Latin America Recent Past, Current & Future Analysis for Microarray Kits by End-Use - CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Latin America Historic Review for Microarray Kits by End-Use - CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 211: Latin America 16-Year Perspective for Microarray Kits by End-Use - Percentage Breakdown of Value Sales for CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use for the Years 2014, 2025 & 2030
    • TABLE 212: Latin America Recent Past, Current & Future Analysis for Microarray Kits by Application - Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Latin America Historic Review for Microarray Kits by Application - Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 214: Latin America 16-Year Perspective for Microarray Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 215: Argentina Recent Past, Current & Future Analysis for Microarray Kits by Product - DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Argentina Historic Review for Microarray Kits by Product - DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 217: Argentina 16-Year Perspective for Microarray Kits by Product - Percentage Breakdown of Value Sales for DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits for the Years 2014, 2025 & 2030
    • TABLE 218: Argentina Recent Past, Current & Future Analysis for Microarray Kits by End-Use - CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Argentina Historic Review for Microarray Kits by End-Use - CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 220: Argentina 16-Year Perspective for Microarray Kits by End-Use - Percentage Breakdown of Value Sales for CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use for the Years 2014, 2025 & 2030
    • TABLE 221: Argentina Recent Past, Current & Future Analysis for Microarray Kits by Application - Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Argentina Historic Review for Microarray Kits by Application - Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 223: Argentina 16-Year Perspective for Microarray Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 224: Brazil Recent Past, Current & Future Analysis for Microarray Kits by Product - DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Brazil Historic Review for Microarray Kits by Product - DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 226: Brazil 16-Year Perspective for Microarray Kits by Product - Percentage Breakdown of Value Sales for DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits for the Years 2014, 2025 & 2030
    • TABLE 227: Brazil Recent Past, Current & Future Analysis for Microarray Kits by End-Use - CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Brazil Historic Review for Microarray Kits by End-Use - CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 229: Brazil 16-Year Perspective for Microarray Kits by End-Use - Percentage Breakdown of Value Sales for CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use for the Years 2014, 2025 & 2030
    • TABLE 230: Brazil Recent Past, Current & Future Analysis for Microarray Kits by Application - Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Brazil Historic Review for Microarray Kits by Application - Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 232: Brazil 16-Year Perspective for Microarray Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 233: Mexico Recent Past, Current & Future Analysis for Microarray Kits by Product - DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Mexico Historic Review for Microarray Kits by Product - DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 235: Mexico 16-Year Perspective for Microarray Kits by Product - Percentage Breakdown of Value Sales for DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits for the Years 2014, 2025 & 2030
    • TABLE 236: Mexico Recent Past, Current & Future Analysis for Microarray Kits by End-Use - CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Mexico Historic Review for Microarray Kits by End-Use - CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 238: Mexico 16-Year Perspective for Microarray Kits by End-Use - Percentage Breakdown of Value Sales for CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use for the Years 2014, 2025 & 2030
    • TABLE 239: Mexico Recent Past, Current & Future Analysis for Microarray Kits by Application - Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Mexico Historic Review for Microarray Kits by Application - Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 241: Mexico 16-Year Perspective for Microarray Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Microarray Kits by Product - DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Latin America Historic Review for Microarray Kits by Product - DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 244: Rest of Latin America 16-Year Perspective for Microarray Kits by Product - Percentage Breakdown of Value Sales for DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits for the Years 2014, 2025 & 2030
    • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Microarray Kits by End-Use - CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Rest of Latin America Historic Review for Microarray Kits by End-Use - CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 247: Rest of Latin America 16-Year Perspective for Microarray Kits by End-Use - Percentage Breakdown of Value Sales for CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use for the Years 2014, 2025 & 2030
    • TABLE 248: Rest of Latin America Recent Past, Current & Future Analysis for Microarray Kits by Application - Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Rest of Latin America Historic Review for Microarray Kits by Application - Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 250: Rest of Latin America 16-Year Perspective for Microarray Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Microarray Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Microarray Kits by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Microarray Kits by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 253: Middle East 16-Year Perspective for Microarray Kits by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 254: Middle East Recent Past, Current & Future Analysis for Microarray Kits by Product - DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Middle East Historic Review for Microarray Kits by Product - DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 256: Middle East 16-Year Perspective for Microarray Kits by Product - Percentage Breakdown of Value Sales for DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits for the Years 2014, 2025 & 2030
    • TABLE 257: Middle East Recent Past, Current & Future Analysis for Microarray Kits by End-Use - CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Middle East Historic Review for Microarray Kits by End-Use - CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 259: Middle East 16-Year Perspective for Microarray Kits by End-Use - Percentage Breakdown of Value Sales for CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use for the Years 2014, 2025 & 2030
    • TABLE 260: Middle East Recent Past, Current & Future Analysis for Microarray Kits by Application - Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Middle East Historic Review for Microarray Kits by Application - Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 262: Middle East 16-Year Perspective for Microarray Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 263: Iran Recent Past, Current & Future Analysis for Microarray Kits by Product - DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Iran Historic Review for Microarray Kits by Product - DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 265: Iran 16-Year Perspective for Microarray Kits by Product - Percentage Breakdown of Value Sales for DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits for the Years 2014, 2025 & 2030
    • TABLE 266: Iran Recent Past, Current & Future Analysis for Microarray Kits by End-Use - CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Iran Historic Review for Microarray Kits by End-Use - CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 268: Iran 16-Year Perspective for Microarray Kits by End-Use - Percentage Breakdown of Value Sales for CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use for the Years 2014, 2025 & 2030
    • TABLE 269: Iran Recent Past, Current & Future Analysis for Microarray Kits by Application - Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Iran Historic Review for Microarray Kits by Application - Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 271: Iran 16-Year Perspective for Microarray Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 272: Israel Recent Past, Current & Future Analysis for Microarray Kits by Product - DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Israel Historic Review for Microarray Kits by Product - DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 274: Israel 16-Year Perspective for Microarray Kits by Product - Percentage Breakdown of Value Sales for DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits for the Years 2014, 2025 & 2030
    • TABLE 275: Israel Recent Past, Current & Future Analysis for Microarray Kits by End-Use - CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Israel Historic Review for Microarray Kits by End-Use - CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 277: Israel 16-Year Perspective for Microarray Kits by End-Use - Percentage Breakdown of Value Sales for CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use for the Years 2014, 2025 & 2030
    • TABLE 278: Israel Recent Past, Current & Future Analysis for Microarray Kits by Application - Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Israel Historic Review for Microarray Kits by Application - Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 280: Israel 16-Year Perspective for Microarray Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Microarray Kits by Product - DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Saudi Arabia Historic Review for Microarray Kits by Product - DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 283: Saudi Arabia 16-Year Perspective for Microarray Kits by Product - Percentage Breakdown of Value Sales for DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits for the Years 2014, 2025 & 2030
    • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Microarray Kits by End-Use - CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Saudi Arabia Historic Review for Microarray Kits by End-Use - CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 286: Saudi Arabia 16-Year Perspective for Microarray Kits by End-Use - Percentage Breakdown of Value Sales for CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use for the Years 2014, 2025 & 2030
    • TABLE 287: Saudi Arabia Recent Past, Current & Future Analysis for Microarray Kits by Application - Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Saudi Arabia Historic Review for Microarray Kits by Application - Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 289: Saudi Arabia 16-Year Perspective for Microarray Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 290: UAE Recent Past, Current & Future Analysis for Microarray Kits by Product - DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: UAE Historic Review for Microarray Kits by Product - DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 292: UAE 16-Year Perspective for Microarray Kits by Product - Percentage Breakdown of Value Sales for DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits for the Years 2014, 2025 & 2030
    • TABLE 293: UAE Recent Past, Current & Future Analysis for Microarray Kits by End-Use - CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: UAE Historic Review for Microarray Kits by End-Use - CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 295: UAE 16-Year Perspective for Microarray Kits by End-Use - Percentage Breakdown of Value Sales for CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use for the Years 2014, 2025 & 2030
    • TABLE 296: UAE Recent Past, Current & Future Analysis for Microarray Kits by Application - Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: UAE Historic Review for Microarray Kits by Application - Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 298: UAE 16-Year Perspective for Microarray Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Microarray Kits by Product - DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Rest of Middle East Historic Review for Microarray Kits by Product - DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 301: Rest of Middle East 16-Year Perspective for Microarray Kits by Product - Percentage Breakdown of Value Sales for DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits for the Years 2014, 2025 & 2030
    • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Microarray Kits by End-Use - CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Rest of Middle East Historic Review for Microarray Kits by End-Use - CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 304: Rest of Middle East 16-Year Perspective for Microarray Kits by End-Use - Percentage Breakdown of Value Sales for CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use for the Years 2014, 2025 & 2030
    • TABLE 305: Rest of Middle East Recent Past, Current & Future Analysis for Microarray Kits by Application - Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Rest of Middle East Historic Review for Microarray Kits by Application - Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 307: Rest of Middle East 16-Year Perspective for Microarray Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
  • AFRICA
    • Microarray Kits Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 308: Africa Recent Past, Current & Future Analysis for Microarray Kits by Product - DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Africa Historic Review for Microarray Kits by Product - DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 310: Africa 16-Year Perspective for Microarray Kits by Product - Percentage Breakdown of Value Sales for DNA Microarray Kits, RNA Microarray Kits, Protein Microarray Kits and Tissue Microarray Kits for the Years 2014, 2025 & 2030
    • TABLE 311: Africa Recent Past, Current & Future Analysis for Microarray Kits by End-Use - CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Africa Historic Review for Microarray Kits by End-Use - CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 313: Africa 16-Year Perspective for Microarray Kits by End-Use - Percentage Breakdown of Value Sales for CROs End-Use, Research & Academic Institutes End-Use, Hospitals & Diagnostic Laboratories End-Use, Other End-Uses and Pharma & Biotech Companies End-Use for the Years 2014, 2025 & 2030
    • TABLE 314: Africa Recent Past, Current & Future Analysis for Microarray Kits by Application - Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 315: Africa Historic Review for Microarray Kits by Application - Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 316: Africa 16-Year Perspective for Microarray Kits by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Research Application, Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제